Clinical Trial Update: Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases [NA]

View source ↗

Summary

This ClinicalTrials.gov entry reports that the trial testing prophylactic HIPEC in colorectal cancer patients at high risk for peritoneal metastases has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Peritoneal Metastases

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Colorectal Cancer, Peritoneal Metastases | NA | Status: COMPLETED